NEW YORK (GenomeWeb News) – RayBiotech announced on Tuesday a partnership to provide biomarker discovery and validation services to the Fox Chase Cancer Center.
The deal with the center's Genomics Core Facility also will provide RayBiotech's GMP-compliant and ISO 13485:2003-certified diagnostic discovery products to researchers throughout Fox Chase's campus. The services and products are based on RayBiotech's antibody array and ELISA product lines, the Norcross, Ga.-based firm said, adding Fox Chase is receiving preferred pricing as part of the deal.
Financial and other terms of the partnership were not disclosed.
RayBiotech announced a master services and supply agreement last week with the Proteomics and Metabolomics Core Facility of Colorado State University to provide biomarker discovery and characterization services.